Cathepsin B and its endogenous inhibitor cystatin C in rheumatoid arthritis synovium

Journal of Rheumatology

Volumn 27, Issue 4, 2000, Pages 859-865

  Hansen, Torsten ^b   Petrow, Peter K ^b   Gaumann, Andreas ^b   Keyszer, Gernot M ^b   Eysel, Peer ^b   Eckardt, Anke ^b   Bräuer, Rolf ^b   Kriegsmann, Jörg ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NONE

Author keywords

Cathepsin B; Cystatin C; Rheumatoid arthritis

Indexed keywords

CATHEPSIN B; CD68 ANTIGEN; CYSTATIN C; ENZYME INHIBITOR;

ADULT; AGED; ARTICLE; BONE DESTRUCTION; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARTHRITIS, RHEUMATOID; CARTILAGE; CATHEPSIN B; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; SYNOVIAL MEMBRANE;

EID: 0034096934     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993;52 Suppl:39-47.
2. Kriegsmann J, Müller-Ladner U, Bräuer R, Gay RE, Gay S. Zur Rolle der Fibroblasten bei der Rheumatoid-Arthritis [The role of fibroblasts in rheumatoid arthritis]. In: Arthritiden. Update: Clinical immunology. Vol. 5. Lengerich: Pabst Publishers; 1997:316-35.
3. Case JP, Lafyatis R, Remmers RF, Kumkumian GK, Wilder RL. Transin/stromelysin expression in rheumatoid synovium. Am J Pathol 1989;135:1055-64.
4. Krane SM, Conca W, Stephenson ML, Amento EP, Goldring MB. Mechanisms of matrix degradation in rheumatoid arthritis. Ann NY Acad Sci 1990;580:340-54.
5. Trabandt A, Gay RE, Fassbender HG, Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 1991;34:1444-51.
6. Keyszer GM, Heer AH, Kriegsmann J, et al. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis by in situ hybridization. Arthritis Rheum 1995;38:976-84.
7. Müller-Ladner U, Kriegsmann J, Franklin BN, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
8. Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999;26:717-9.
9. Maciewicz RA, Wotton SF. Degradation of cartilage matrix components by the cysteine proteinases, cathepsins B and L. Biomed Biochim Acta 1991;50:561-4.
10. Van Noorden CJ, Smith RE, Rasnick D. Cysteine proteinase activity in arthritic rat knee joints and the effects of a selective systemic inhibitor, Z-Phe-AlaCH2F. J Rheumatol 1988;15:1525-35.
11. Baumgrass R, Williamson MK, Price PA. Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H and S. J Bone Miner Res 1997;12:447-55.
12. Sires UI, Schmid TM, Fliszar CJ, Wang ZQ, Gluck SL, Welgus HG. Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin B. J Clin Invest 1995;95:2089-95.
13. Eeckhout Y, Vaes G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase: effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 1977;166:21-31.
14. Murphy G, Ward R, Gavrilovic J, Atkinson S. Physiological mechanisms for metalloproteinase activation. Matrix 1992;1 Suppl:224-30.
15. Hall A, Håkansson K, Mason RW, Grubb A, Abrahamson M. Structural basis for the biological specificity of cystatin C. J Biol Chem 1995;270:5115-21.
16. Grubb A, Löfberg H. Human γ-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982;79:3024-7.
17. Abrahamson M, Barrett AJ, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. J Biol Chem 1986;261:11282-9.
18. Abrahamson M, Olafsson I, Palsdottir A, et al. Structure and expression of the human cystatin C gene. Biochem J 1990; 268:287-94.
19. Abrahamson M, Mason RW, Hansson H, Buttle DJ, Grubb A, Ohlsson K. Human cystatin C: role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J 1991;273:621-6.
20. Nycander M, Estrada S, Mort JS, Abrahamson M, Björk I. Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop. FEBS Lett 1998;422:61-4.
21. Lenarcic B, Gabrijelcic D, Rozman B, Drobnic-Kosorok M, Turk V. Human cathepsin B and cysteine proteinase inhibitors in inflammatory and metabolic joint diseases. Biol Chem Hoppe-Seyler 1988;369:257-61.
22. Keyszer G, Redlich A, Häupl T, et al. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1998;41:1378-87.
23. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Müller-Ladner U, Kriegsmann J, Tschopp J, Gay RE, Gay S. Demonstration of granzyme A and perform messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:477-84.
25. Hummel KM, Petrow PK, Franz JK, et al. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 1998;25:1887-94.
26. Barland P, Novikoff AB, Hamerman D. Electron microscopy of the human synovial membrane. J Cell Biol 1962;14:207-20.
27. Wilkinson LS, Pitsillides AA, Worral JG, Edwards JCW. Light microscopic characterization of the fibroblast-like synovial intimal cell (synoviocyte). Arthritis Rheum 1992;35:1179-84.
28. Falini B, Flenghi L, Piler S, et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993;142:1359-72.
29. Kriegsmann J, Müller-Ladner U, Tischer M, et al. Nachweis der CD68-Expression in Synovialgeweben von Patienten mit Rheumatoid-Arthritis [Expression of CD68 in synovial tissue of patients with rheumatoid arthritis] [abstract]. Z Rheumatol 1996;55 Suppl:91.
30. Warfel AH, Zucker-Franklin D, Frangione B, Ghiso J. Constitutive secretion of cystatin C (γ-trace) by monocytes and macrophages and its downregulation after stimulation. J Exp Med 1987;166:1912-7.
31. Chapman HA, Reilly JJ, Yee R, Grubb A. Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis 1990;141:698-705.
32. van der Reijden WA, van der Kwaak JS, Veerman ECI, Nieuw-Amerongen AV. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome. Eur J Oral Sci 1996;104:335-40.
33. Henskens YMC, Veerman ECI, Mantel MS, van der Velden U, Nieuw Amerongen AV. Cystatins S and C in human whole saliva and in glandular salivas in periodontal health and disease. J Dent Res 1994;73:1606-14.
34. Trabandt A, Müller-Ladner U, Kriegsmann J, Gay RE, Gay S. Expression of proteolytic cathepsins B, D, and L in periodontal gingival fibroblasts and tissues. Lab Invest 1995;73:205-12.
35. Solem M, Rawson C, Lindburg K, Barnes D. Transforming growth factor beta regulates cystatin C in serum-free mouse embryo cells. Biochem Biophys Res Commun 1990;172:945-51.
36. Taketazu F, Kato M, Gobl A, et al. Enhanced expression of transforming growth factor-β s and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest 1994;70:620-30.
37. Mort JS, Recklies AD, Poole AR. Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum 1984;27:509-15.
38. Drake FH, Dodds RA, James IE, et al. Cathepsin K, but not cathepsin B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 1996;271:12511-6.
39. Lerner UH, Johansson L, Ransjö M, Rosenquist JB, Reinholt FP, Grubb A. Cystatin C, an inhibitor of bone resorption produced by osteoblasts. Acta Physiol Scand 1997;161:81-92.
40. Ohsawa Y, Nitatori T, Higuchi S, Kominami E, Uchiyama Y. Lysosomal cysteine and aspartic proteinases, acid phosphatase, and an endogenous cysteine proteinase inhibitor, cystatin-β, in rat osteoclasts. J Histochem Cytochem 1993;41:1075-83.
41. Moroi R, Yamaza T, Nishiura Y, et al. Immunocytochemical study of cathepsin L and rat cystatin-3 in rat osteoclasts treated with E-64 in vivo. Arch Oral Biol 1997;42:305-15.